N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositio

Details N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositio N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositio

1993-06-21

1995-10-17

Bond, Robert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

540557, A61K 3155, C07D24302

Patent

active

054591376

ABSTRACT:
The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in the specification, a more complete description of the compounds may be found.
The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.

REFERENCES:
patent: 4614740 (1986-09-01), Lang et al.
patent: 4835152 (1989-05-01), Korosi et al.
Tarnawa et al., "Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466", European J. Pharmacol., 167, 193-199 (1989).
Tarnawa, Engberg, and Flatman, GYKI 52466, an inhibitor of spinal reflexes is a potent quisqualate antagonists, in Amino Acids, Chemistry, Biology and Medicine, 538-46 (1990).
Ouardouz and Durand, "GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones", Neuroscience Lett., 125, 5-8 (1991).
Moncada et al., "Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus", Neuroscience Lett., 133, 287-290 (1991).
Arvin et al., "GYKI 52466 blocks the increase in extracellular glutamate induced by ischaemia", NeuroReport, 3, 235-238 (1992).
Smith and Meldrum, "Cerebroprotective effect of a Non-N-Methyl-D-Aspartate Antagonist, GYKI 52466, After Focal Ischemia in the Rat", Stroke, 23, 861-864 (1992).
Smith et al., "The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy", European J. Pharmacol., 201, 179-183 (1991).
Chapman et al., "The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice", Epilepsy Res., 9, 92-96 (1991).
Peillet et al., "The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat", Brain Res., 571, 115-120 (1992).
Smith and Meldrum, "Receptor site specificity for the acute effects of .beta.-N-methylamino-alanine in mice", European J. Pharmacol., 187, 131-134 (1990).
Tarnawa et al., "Structure-Activity Relationship of 2,3-Benzodiazepine Compounds with Glutamte Antagonists Action", Bioorganic & Medicinal Chem. Lett., 3, 99-104 (1993).
Zorumski et al., "A Benzodiazepine Recognition Site Associated with the Non-NMDA Glutamte Receptor", Neuron, 10, 61-67 (1993).
Donevan and Rogawski, "GYKI 52466, a 2,3-Benzodiazepine, IS a Highly Selective, Noncompetitive Antagonist of AMPA/Kainate Receptor Responses", Neuron, 10, 51-59 (1993).
Palmer and Lodge, "Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655", Eur J Pharmacol, 244, 193-194 (1993).
Lodge et al., Electrophysiology of glutamate receptors, in Drug Research Related to Neuroactive Amino Acids, 153-160 (1992).

Affiliated with

Also associated with

Rating

N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositio will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-597442